![Kensuke Tomita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kensuke Tomita
Director/Board Member at
ECS Co., Ltd.
Net worth: 4 M $ as of 2026-09-29
Profile
Kensuke Tomita currently works at ECS Co., Ltd., as Director from 2003.
Mr. Tomita also formerly worked at OncoTherapy Science, Inc., as President & Chief Executive Officer from 2002 to 2011, StemRIM, Inc., as Executive Chairman from 2023 to 2024, and MEDINET Co., Ltd., as Outside Director from 2014 to 2016.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
STEMRIM INC. 5.17% | 2026-08-12 | 3,241,900 ( 5.17% ) | 4 M $ | 2026-09-29 |
Kensuke Tomita active positions
| Companies | Position | Start |
|---|---|---|
ECS Co., Ltd.
 ECS Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Offers consulting services | Director/Board Member | 1991-09-30 |
Former positions of Kensuke Tomita
| Companies | Position | End |
|---|---|---|
| STEMRIM | Chief Executive Officer | 2023-10-24 |
| MEDINET CO., LTD. | Director/Board Member | 2016-01-21 |
| ONCOTHERAPY SCIENCE, INC. | Chairman | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
ECS Co., Ltd.
ECS Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Offers consulting services | Commercial Services |
OncoTherapy Science, Inc.
 OncoTherapy Science, Inc. BiotechnologyHealth Technology Engages in the research and development of cancer vaccines and antibody drugs | Health Technology |
MEDINET Co., Ltd.
 MEDINET Co., Ltd. BiotechnologyHealth Technology Engages in the contract development and manufacturing organization which provides regenerative medicine & cell therapy services | Health Technology |
StemRIM, Inc.
 StemRIM, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of regenerative drugs | Commercial Services |
- Stock Market
- Insiders
- Kensuke Tomita
